Live Breaking News & Updates on Oxford Vaccine South Africa Variant

Oxford AstraZeneca vaccine efficacy: Boris Johnson said vaccines remain of massive benefit to the UK (Image: GETTY)
READ MORE
But a recent study of some 2,000 young people has shown the Oxford vaccine only offers minimal protection against mild and moderate infection from the South African Covid variant.
However, the study could not conclude whether the vaccine also worked against severe disease due to the young age of the trial participants, who were on average aged 31.
Andrew Pollard, chief investigator on the Oxford vaccine trial, said: This study confirms that the pandemic coronavirus will find ways to continue to spread in vaccinated populations, as expected. ....

South Africa , United Kingdom , South African , Andrew Pollard , Edward Argar , Oxford Astrazeneca , Sarah Gilbert , Andrew Neil , Nadhim Zahawi , Boris Johnson , Oxford University Astrazeneca Covid , Astrazeneca Covid , South East England , Privacy Notice , South African Covid , Monday Oxford , Vaccine Minister Nadhim Zahawi , Ctp Video , Autoplay Video , Oxford Vaccine , Oxford Vaccine Efficacy , Astrazeneca Vaccine Efficacy , Oxford Vaccine South Africa Variant , South Africa Variant , Vaccine South African Variant , ஒன்றுபட்டது கிஂக்டம் ,